retatrutide weight loss drug Unapproved weight-loss "reta" sold online despite safety concerns Retatrutide vs Tirzepatide vs Semaglutide

This study highlights the importance of considering both the benefits and drawbacks of using GLP-1 agonists

Body changes: Track your body weight, changes in appetite or cravings, any episodes of nausea or vomiting, and your calorie intake

All proposed interventions should be evaluated against their potential to reduce the incidence and prevalence of AD/ADRD, as well as inequalities

Eat Smaller, More Frequent Meals: GLP-1s slow stomach emptying

Abstract This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity